{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T09:45:30Z","timestamp":1775641530629,"version":"3.50.1"},"reference-count":48,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T00:00:00Z","timestamp":1327881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p><jats:bold>Purpose:\u2002<\/jats:bold>To evaluate the long\u2010term effects and costs of four treatment strategies for primary open\u2010angle glaucoma compared to usual care.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>Cost\u2010effectiveness analyses with a lifelong horizon were made from a societal perspective. Data were generated with a patient\u2010level model based on discrete event simulation. The model structure and parameter estimates were based on literature, particularly clinical studies on the natural course of glaucoma and the effect of treatment. We simulated heterogeneous cohorts of 3000 patients and explored the impact of uncertainty with sensitivity analyses.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>The incremental cost\u2010effectiveness ratio (ICER) of initial treatment with a prostaglandin analogue compared with a \u03b2\u2010blocker was \u20ac12.931 per quality\u2010adjusted life year (QALY) gained. A low initial target pressure (15\u2003mmHg) resulted in 0.115 QALYs gained and \u20ac1550 saved compared to a gradual decrease from 21 to 15\u2003mmHg upon progression. Visual field (VF) measurements every 6 rather than 12\u2003months lead to health gains at increased costs (ICER \u20ac173\u2003486 per QALY gained), whereas measurements every 24\u2003months lead to health losses at reduced costs (ICER \u20ac21\u2003516 per QALY lost). All treatment strategies were dominant over \u2018withholding treatment\u2019.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold>From a cost\u2010effectiveness point of view, it seems advantageous to aim for a low intraocular pressure in all glaucoma patients. The feasibility of this strategy should therefore be investigated. Additionally, the cost\u2010effectiveness outcomes of initiating monotherapy with a prostaglandin analogue and reducing the frequency of VF testing may be acceptable.<\/jats:p>","DOI":"10.1111\/j.1755-3768.2011.02318.x","type":"journal-article","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T18:37:26Z","timestamp":1327948646000},"page":"20-31","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The long\u2010term outcomes of four alternative treatment strategies for primary open\u2010angle glaucoma"],"prefix":"10.1111","volume":"90","author":[{"given":"Aukje","family":"van Gestel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carroll A.","family":"Webers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan L.","family":"Severens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henny J.","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nomdo M.","family":"Jansonius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Hendrikse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan S.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,30]]},"reference":[{"key":"e_1_2_6_2_1","volume-title":"Preferred practice pattern. Primary open\u2010angle glaucoma","author":"American Academy of Ophthalmology Glaucoma Panel","year":"2005"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.297"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision modelling for health economic evaluation","author":"Briggs A","year":"2006"},{"key":"e_1_2_6_5_1","first-page":"CD004399.pub2","article-title":"Medical versus surgical interventions for open angle glaucoma","volume":"2","author":"Burr J","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0b013e3181339f30"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.135012"},{"key":"e_1_2_6_8_1","volume-title":"Threshold values for cost\u2010effectiveness in health care Health Technology Assessment (HTA)","author":"Cleemput I","year":"2008"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2008.08.006"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2008.00489.x"},{"key":"e_1_2_6_11_1","volume-title":"Terminology and guidelines for glaucoma (second edition)","author":"European Glaucoma Society","year":"2003"},{"key":"e_1_2_6_12_1","volume-title":"Terminology and guidelines for glaucoma (third edition)","author":"European Glaucoma Society","year":"2008"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9801800117"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2005.10.023"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X167327"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X09342277"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.10.1268"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.06.042"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-005-0032-5"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2005.00621.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-6296(94)00044-5"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462310000048"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)00912-6"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.1.12"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.03.016"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00873-9"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.7.1050"},{"key":"e_1_2_6_28_1","first-page":"S20","article-title":"Current management of glaucoma and the need for complete therapy","volume":"14","author":"McKinnon S","year":"2008","journal-title":"Am J Manag Care"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(86)90457-5"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.02.017"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.655"},{"key":"e_1_2_6_32_1","article-title":"Latanoprost versus timolol as first choice therapy in patients with ocular hypertensionA cost\u2010effectiveness analysis","author":"Peeters A","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"e_1_2_6_33_1","unstructured":"PoosMandGijsenR(2010):National Compass of Public Health; Explorations of the future [Volksgezondheid Toekomst Verkenning Nationaal Kompas Volksgezondheid].Visual disorders by age and sex [Gezichtsstoornissen naar leeftijd en geslacht]. RIVM Bilthoven."},{"key":"e_1_2_6_34_1","volume-title":"Zinnige en duurzame zorg (Sensible and sustainable care)","author":"Raad voor Volksgezondheid en Zorg (Council for Public Health and Health Care)","year":"2006"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.12.056"},{"key":"e_1_2_6_36_1","volume-title":"Guidelines for pharmacoeconomic research (version 2006)","author":"Rodenburg\u2010Van Dieten H","year":"2005"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200523120-00005"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1159\/000310397"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e3283360ac3"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200826020-00004"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(00)00538-9"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199507060-00005"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.067355"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2007.01065.x"},{"key":"e_1_2_6_45_1","volume-title":"National Eye Institute Visual Functioning Questionnaire\u201025: Dutch consensus translation (VFQ\u201025\/NL)","author":"Van der Sterre G","year":"2001"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00678.x"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2010.133"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e328332f562"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1076\/iaij.4.1.5.16466"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-3768.2011.02318.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1755-3768.2011.02318.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T17:21:19Z","timestamp":1713460879000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-3768.2011.02318.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,30]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1111\/j.1755-3768.2011.02318.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1755-3768.2011.02318.x","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,30]]},"assertion":[{"value":"2012-01-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}